EDGAR Filing Documents for 0001136261-18-000308

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001136261-18-000308

Filing Date

2018-11-13

Accepted

2018-11-09 18:58:03

Documents

Period of Report

2018-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	body10q.htm	10-Q	1111991
2	ARTICLES SUPPLEMENTARY FOR 0% SERIES C PERPETUAL CONVERTIBLE PREFERRED STOCK	exh3-1.htm	EX-3.1	147239
3	STOCKHOLDERS AGREEMENT, DATED JULY 27, 2018, BY AND AMONG NALPROPION PHARMACEUTI	exh10-1.htm	EX-10.1	420242
4	SERVICES AGREEMENT, DATED JULY 27, 2018, BETWEEN NALPROPION PHARMACEUTICALS, INC	exh10-2.htm	EX-10.2	283300
5	AMENDMENT NO. 3 TO THE ABL FACILITY, AUGUST 1, 2018, BY AND AMONG PERNIX, THE GU	exh10-6.htm	EX-10.6	60335
6	AMENDMENT NO. 2 TO THE TERM FACILITY, DATED AUGUST 1, 2018, BY AND AMONG PIP DAC	exh10-7.htm	EX-10.7	53789
7	FIRST SUPPLEMENTAL INDENTURE, DATED JULY 27, 2018, BETWEEN PERNIX THERAPEUTICS H	exh10-8.htm	EX-10.8	45877
8	CEO 302 CERTIFICATE	exh31-1.htm	EX-31.1	5000
9	CFO 302 CERTIFICATE	exh31-2.htm	EX-31.2	4786
10	906 CERTIFICATE	exh32-1.htm	EX-32.1	3266
11	LOGO	image1904.jpg	GRAPHIC	6415
	Complete submission text file	0001136261-18-000308.txt		6935239

Data Files

Seq	Description	Document	Type	Size
12	XBRL INSTANCE DOCUMENT	ptx-20180930.xml	EX-101.INS	1282318
13	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	ptx-20180930.xsd	EX-101.SCH	56500
14	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	ptx-20180930_cal.xml	EX-101.CAL	90554
15	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	ptx-20180930_def.xml	EX-101.DEF	180594
16	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	ptx-20180930_lab.xml	EX-101.LAB	449027
17	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	ptx-20180930_pre.xml	EX-101.PRE	340392

Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960

Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457

PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)